A novel artificial intelligence biomarker: Validation of the automated bone scan index (aBSI) in veterans with metastatic prostate cancer.

被引：0
|
作者：
Durkal, Vipal P.
Nickols, Nicholas George
Rettig, Matthew
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17507
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
    Mota, Jose Mauricio
    Armstrong, Andrew J.
    Larson, Steven M.
    Fox, Josef J.
    Morris, Michael J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 522 - 530
  • [32] Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
    Jose Mauricio Mota
    Andrew J. Armstrong
    Steven M. Larson
    Josef J. Fox
    Michael J. Morris
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 522 - 530
  • [33] Bone Scan Index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients
    Rasmussen, J.
    Poulsen, M.
    Johansen, A.
    Lund, L.
    Hoilund-Carlsen, P.
    Gerke, O.
    Edenbrandt, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S470 - S470
  • [34] Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer
    Poulsen, Mads H.
    Rasmussen, Janne
    Edenbrandt, Lars
    Hoilund-Carlsen, Poul F.
    Gerke, Oke
    Johansen, Allan
    Lund, Lars
    BJU INTERNATIONAL, 2016, 117 (05) : 748 - 753
  • [35] Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index
    Reza Kaboteh
    Peter Gjertsson
    Håkan Leek
    Milan Lomsky
    Mattias Ohlsson
    Karl Sjöstrand
    Lars Edenbrandt
    EJNMMI Research, 3
  • [36] Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index
    Kaboteh, Reza
    Gjertsson, Peter
    Leek, Hakan
    Lomsky, Milan
    Ohlsson, Mattias
    Sjostrand, Karl
    Edenbrandt, Lars
    EJNMMI RESEARCH, 2013, 3 : 1 - 6
  • [37] Value of bone scan index for predicting overall survival among patients treated with radium-223 for bone metastatic castration-resistant prostate cancer.
    Yoneyama, Shuko
    Miyoshi, Yasuhide
    Tsutsumi, Sohgo
    Kawahara, Takashi
    Hattori, Yusuke
    Yokomizo, Yumiko
    Hayashi, Narihiko
    Yao, Masahiro
    Uemura, Hiroji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [38] Quantitative imaging by automated bone scan index (BSI) as a response biomarker in standard clinical care of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.
    Anand, Aseem
    Belal, Sarah Lindgren
    Reza, Mariana
    Edenbrandt, Lars
    Bjartell, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [39] Initial analytic validation of automated bone scan measures for treatment response assessment in patients with metastatic castration-resistant prostate cancer (CRPC).
    Chu, G. H.
    Brown, M. S.
    Kim, H. J.
    Auerbach, M.
    Poon, C.
    Ramakrishna, B.
    Vidovic, A.
    Gjertson, D. W.
    Morris, M. J.
    Larson, S. M.
    Goldin, J. G.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Clinical Significance of the Highest Regional Bone Scan Index in Patients with Metastatic Castration–Resistant Prostate Cancer
    Yasushi Nakai
    Yusuke Iemura
    Toshiteru Miyasaka
    Shunta Hori
    Makito Miyake
    Nagaaki Marugami
    Kiyohide Fujimoto
    Nobumichi Tanaka
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 221 - 227
12345